Benign neoplasm of meninges

CD2_BENIGN_MENINGES

obsolete_meningioma: ['A tumor of meningothelial cells that are manifested in the central nervous system and arise from the arachnoid "cap" cells of the arachnoid villi in the meninges.']

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D32
  • Cause of death: ICD-10 D32

2 out of 7 registries used, show all original rules.

3739

4. Check minimum number of events

None

3739

5. Include endpoints

3841

6. Filter based on genotype QC (FinnGen only)

3841

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Neoplasma benignum meningum

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 24691 18210 6316
Only index persons 21257 16014 5243
Unadjusted period prevalence (%)
Whole population 0.43 0.52 0.18
Only index persons 0.49 0.59 0.20
Median age at first event (years)
Whole population 64.58 64.77 64.01
Only index persons 63.92 64.05 63.52

-FinnGen-

Key figures

All Female Male
Number of individuals 3841 2886 955
Unadjusted period prevalence (%) 0.84 0.98 0.42
Median age at first event (years) 62.61 61.52 65.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3394
Matched controls
33940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
2251.8
323.0
376
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
+∞
323.0
536
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
20.1
323.0
1444
1207
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
+∞
323.0
1041
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
+∞
323.0
507
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
422.8
323.0
1238
46
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
16384.0
323.0
1849
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
1424.5
323.0
855
8
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
302.7
286
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
1260.6
243.6
235
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
40.0
238.2
303
83
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
14.1
230.0
409
327
AA1AD
NOMESCO Finland
CT of head and brain
3.4
208.1
1358
5561
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
198.9
189
*
D32.05
ICD-10 Finland
Cerebral meninges
+∞
193.6
184
*
N03AX14
ATC
levetiracetam; systemic
12.8
186.3
345
298
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.4
185.7
474
725
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.2
182.0
635
1448
D32.03
ICD-10 Finland
Benign meningioma in ventricles
1684.7
161.7
156
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
100.7
148.5
163
17
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
146.2
879
3219
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
141.6
135
*
H02AB02
ATC
dexamethasone; systemic
3.8
140.3
695
2176
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
129.0
123
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
11.0
126.4
250
243
ZXC95
NOMESCO Finland
Use of surgical navigator
16.6
122.5
201
128
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
121.6
116
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.5
115.8
224
208
N03AF02
ATC
oxcarbazepine; oral
7.6
115.0
283
400
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
29.3
101.2
138
49
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
100.5
96
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.3
93.5
202
230
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.9
85.1
188
222
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
84.9
1123
6176
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
+∞
80.5
77
*
2152
FHL
Extraction, big brain
126.0
80.3
86
7
XCK00
NOMESCO Finland
Perimetry
3.5
80.0
418
1321
H53.4
ICD-10 Finland
Visual field defects
7.4
79.2
197
281
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
77.4
74
*
WX882
NOMESCO Finland
High dependency care
6.6
74.4
200
318
R51.80
ICD-10 Finland
Headache
2.6
71.4
625
2758
N03AB02
ATC
phenytoin; systemic
10.7
68.1
135
131
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.6
65.9
202
380
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
64.8
62
*
D32
ICD-10 Finland
Benign neoplasm of meninges
+∞
64.8
62
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
49.8
64.6
78
16
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.1
63.1
210
434
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
9.5
61.3
129
140
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
60.6
58
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.6
59.3
159
252
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
+∞
58.5
56
*
N03AF01
ATC
carbamazepine; oral, rectal
3.6
57.6
281
833
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
54.3
679
3521
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
54.0
829
4687
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
16.5
51.8
84
52
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.4
51.8
199
477
N75
ICPC
Benign neoplasm nervous system
179.4
51.0
53
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
10.2
50.0
101
102
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
49.0
197
493
ZXC40
NOMESCO Finland
Use of ultrasound
11.1
48.2
93
86
D33.30
ICD-10 Finland
Acoustic neuroma
12.3
45.8
84
70
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
10.2
44.8
90
90
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
17.4
44.2
70
41
H47.2
ICD-10 Finland
Optic atrophy
18.0
44.1
69
39
WX110
NOMESCO Finland
Local anesthesy
1.7
43.5
2228
18072
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.8
42.2
92
107
AAK00
NOMESCO Finland
Cranioplasty
47.0
42.0
51
11
A02BC02
ATC
pantoprazole; systemic
1.7
41.6
2269
18597
N02BE01
ATC
paracetamol; systemic, rectal
2.0
40.6
2962
26416
WX402
NOMESCO Finland
General anaesthesia
2.0
39.9
592
3251
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.0
39.9
81
83
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
39.8
209
654
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.4
39.6
72
59
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
39.6
463
2301
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
58.2
39.3
46
8
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
65.1
39.1
45
7
N76
ICPC
Neoplasm nervous system unspecified
36.2
39.1
50
14
R42
ICD-10 Finland
Dizziness and giddiness
1.8
39.0
842
5275
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
63.6
38.1
44
7
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.3
38.0
382
1769
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.7
37.8
83
98
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
21.5
37.4
55
26
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
36.1
337
1504
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
361.0
36.0
36
*
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
186.9
35.8
37
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.2
35.5
71
71
G40.10
ICD-10 Finland
Simple partial seizures
9.4
35.5
74
80
R4110
NOMESCO Finland
Physiotherapy
1.7
33.7
935
6274
N03AG01
ATC
valproic acid; systemic, rectal
2.7
33.5
241
929
H02AB09
ATC
hydrocortisone; systemic
4.4
33.3
124
289
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
330.2
32.9
33
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
117.8
32.7
35
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
37.7
32.4
41
11
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
8.3
32.4
73
90
WF002
NOMESCO Finland
Radical radiotherapy
3.0
31.7
189
647
TAB00
NOMESCO Finland
Lumbar puncture
3.0
30.8
190
666
H53.2
ICD-10 Finland
Diplopia
3.6
30.8
144
412
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
31.1
30.3
40
13
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
13.9
30.3
52
38
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
14.6
29.2
49
34
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
32.0
29.0
38
12
CS494
NOMESCO Finland
Other visual field testing
3.8
28.6
125
338
WF099
NOMESCO Finland
Other radiotherapy
9.2
28.6
60
66
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.7
27.7
60
70
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.0
27.1
62
79
WX872
NOMESCO Finland
Intensive care
2.8
27.1
188
708
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
26.2
495
2926
N03AX18
ATC
lacosamide; systemic
9.8
26.2
53
55
S18
ICPC
Laceration/cut
1.5
25.5
1386
10773
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
7.8
25.5
59
77
101
Kela drug reimbursment
Anterior pituitary hypofunction
12.0
24.7
45
38
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.3
24.2
244
1125
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
24.1
471
2810
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
23.9
326
1712
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
23.6
778
5375
183
Kela drug reimbursment
Lamotrigin and topiramate
6.9
23.5
59
87
SPAT1153
SPAT
Removal of sutures
1.5
23.3
1096
8211
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
33.6
23.3
30
9
H47.1
ICD-10 Finland
Papilloedema, unspecified
10.1
23.2
46
46
E23.00
ICD-10 Finland
Panhypopituitarism
11.4
23.1
43
38
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.6
22.6
53
71
9537/0-C70.9
ICD-O-3
Transitional meningioma of meninges, NOS
+∞
21.9
21
*
9531/0-C70.9
ICD-O-3
Meningothelial meningioma of meninges, NOS
+∞
21.9
21
*
D33.43
ICD-10 Finland
Spinal cord
115.8
21.6
23
*
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
+∞
20.8
20
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.2
20.8
79
190
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
77.3
20.7
23
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
13.6
20.5
35
26
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
41.9
20.4
25
6
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
22.5
20.4
29
13
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
20.3
357
2052
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
20.2
1397
11216
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.1
20.2
45
56
2254A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
19.8
19
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
19.7
525
3414
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
19.7
114
385
N03AX16
ATC
pregabalin; oral
1.5
19.6
785
5642
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
19.4
220
1070
N06AX11
ATC
mirtazapine; oral
1.4
19.1
1009
7675
N05CF01
ATC
zopiclone; oral
1.4
19.0
1083
8359
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
55.3
18.9
22
*
L28
ICPC
Limited function/disability (L)
1.6
18.7
550
3669
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
18.5
653
4549
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
44.2
18.2
22
5
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
52.8
17.9
21
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
17.6
243
1282
2312
FHL
Extirpation or destruction
95.5
17.6
19
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
95.5
17.6
19
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
180.9
17.5
18
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
17.4
174
800
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
7.0
17.1
42
61
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
9.3
17.1
35
38
N01
ICPC
Headache
1.9
17.1
270
1495
N03AX12
ATC
gabapentin; oral
1.6
17.1
508
3393
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.1
17.1
46
76
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
31.6
17.0
22
7
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
13.3
16.9
29
22
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
13.3
16.9
29
22
G44.2
ICD-10 Finland
Tension-type headache
1.6
16.9
424
2708
H93.1
ICD-10 Finland
Tinnitus
2.0
16.7
213
1089
R4120
NOMESCO Finland
Occupational therapy
2.0
16.6
208
1055
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
11.6
16.5
30
26
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.5
16.3
77
225
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.7
16.3
41
62
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
7.6
16.1
37
49
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
60.3
15.8
18
*
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
15.7
292
1706
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
4.5
15.5
54
121
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
15.4
1423
11820
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.0
15.4
90
308
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
8.7
15.2
32
37
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
20.1
15.1
22
11
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
11.8
15.0
27
23
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.3
15.0
138
612
R53
ICD-10 Finland
Malaise and fatigue
1.5
14.8
641
4649
N74
ICPC
Malignant neoplasm nervous system
31.8
14.8
19
6
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
+∞
14.6
14
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
80.4
14.6
16
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
80.4
14.6
16
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.5
14.6
116
476
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
8.9
14.4
30
34
ZXA05
NOMESCO Finland
Left side
1.4
14.3
838
6433
G91.1
ICD-10 Finland
Obstructive hydrocephalus
7.7
14.1
32
42
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
14.1
201
1074
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.2
14.1
73
231
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.2
14.0
52
124
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
14.0
1172
9541
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
14.5
14.0
23
16
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.8
14.0
58
153
WX704
NOMESCO Finland
Intubation
1.9
14.0
221
1223
N05BA01
ATC
diazepam; systemic, rectal
1.6
13.9
421
2813
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
13.7
227
1276
N18
ICPC
Paralysis/weakness
3.1
13.7
74
241
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.7
13.5
93
354
2151
FHL
Resection, big brain
34.2
13.5
17
5
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
13.5
315
1971
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
13.5
192
1025
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
13.4
306
1901
AAK10
NOMESCO Finland
Repair of dura
18.3
13.4
20
11
ZXA00
NOMESCO Finland
Right side
1.4
13.1
872
6829
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
13.0
648
4814
N03AX11
ATC
topiramate; oral
2.8
13.0
85
312
XKD00
NOMESCO Finland
Uroflowmetry
1.6
12.8
367
2420
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
12.8
526
3759
R51
ICD-10 Finland
Headache
2.0
12.8
154
772
G40.89
ICD-10 Finland
Other epilepsy
8.5
12.7
27
32
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.8
12.7
79
282
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
12.7
58
167
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
12.7
111
481
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
70.1
12.6
14
*
ZXC86
NOMESCO Finland
Use of endoscopic device
6.2
12.5
33
54
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.6
12.5
91
358
N28
ICPC
Limited function/disability (N)
3.4
12.5
59
175
M03BX01
ATC
baclofen; systemic
3.3
12.3
62
193
R13
ICD-10 Finland
Dysphagia
1.8
12.2
212
1211
A02BC05
ATC
esomeprazole; systemic
1.3
12.2
1278
10698
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
12.2
195
1086
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.8
12.1
79
290
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.7
11.8
50
136
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
11.7
908
7263
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
30.1
11.6
15
5
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
23.0
11.6
16
7
WX002
NOMESCO Finland
Sedation and analgesia
1.4
11.5
616
4629
G82.2
ICD-10 Finland
Paraplegia, unspecified
6.5
11.5
29
45
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
11.5
348
2324
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
9.3
11.5
23
25
9532/0-C70.9
ICD-O-3
Fibrous meningioma of meninges, NOS
+∞
11.5
11
*
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.6
11.4
83
325
UKC02
NOMESCO Finland
Cystoscopy
1.5
11.4
446
3151
G91.0
ICD-10 Finland
Communicating hydrocephalus
6.7
11.4
28
42
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
11.4
960
7769
A28
ICPC
Limited function/disability NOS
1.5
11.4
481
3454
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.4
11.4
40
92
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.3
11.4
29
46
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
11.3
279
1772
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
11.3
296
1909
S06.0
ICD-10 Finland
Concussion
1.6
11.3
288
1843
ZXA10
NOMESCO Finland
Bilateral
1.4
11.2
589
4409
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
17.1
11.2
17
10
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.6
11.1
49
138
AA1AA
NOMESCO Finland
Head X-ray examination
4.5
11.1
38
85
H02AB06
ATC
prednisolone; systemic
1.3
11.1
1423
12199
A02BC01
ATC
omeprazole; systemic
1.3
11.1
854
6816
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
11.0
181
1019
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
11.0
96
417
2159
FHL
Other measure in this category
43.4
10.9
13
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
10.9
317
2098
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
10.6
10.8
20
19
N03AX09
ATC
lamotrigine; oral
2.1
10.7
120
584
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
21.5
10.7
15
7
H05.2
ICD-10 Finland
Exophthalmic conditions
7.5
10.6
24
32
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
60.2
10.6
12
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
60.2
10.6
12
*
H46
ICD-10 Finland
Optic neuritis
4.5
10.5
36
81
R4130
NOMESCO Finland
Speech therapy
2.6
10.5
72
276
102
Kela drug reimbursment
Diabetes insipidus
10.0
10.5
20
20
G51.0
ICD-10 Finland
Bell palsy
2.5
10.5
82
338
G992, D321
ICD-10 Finland
NA
+∞
10.4
10
*
9533/0-C70.0
ICD-O-3
Psammomatous meningioma of cerebral meninges
+∞
10.4
10
*
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
32.6
10.3
13
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
23.4
10.2
14
6
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.2
911
7413
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.3
10.1
91
403
P20
ICPC
Memory disturbance
1.5
10.0
389
2741
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
40.2
10.0
12
*
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
40.2
10.0
12
*
N80
ICPC
Head injury other
2.9
9.9
57
196
K07.60
ICD-10 Finland
Snapping jaw
1.9
9.8
133
700
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
8.1
9.8
21
26
G47.3
ICD-10 Finland
Sleep apnoea
1.4
9.8
539
4062
N06AX16
ATC
venlafaxine; oral
1.5
9.8
369
2587
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
9.7
291
1941
N04BC06
ATC
cabergoline; oral (dopamine agonists)
7.4
9.7
22
30
N06AX26
ATC
vortioxetine; oral
1.9
9.7
140
756
N06AX21
ATC
duloxetine; oral
1.5
9.7
311
2107
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
9.7
308
2082
K91
ICPC
Cerebrovascular disease
3.1
9.6
50
161
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
9.6
243
1552
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
3.4
9.6
45
135
N06AB10
ATC
escitalopram; oral
1.4
9.5
511
3833
N05BA09
ATC
clobazam; oral
6.0
9.5
25
42
N29
ICPC
Neurological sympt/complt other
2.5
9.4
71
286
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.4
1864
16722
A02BA02
ATC
ranitidine; systemic
1.4
9.4
614
4758
Q85.1
ICD-10 Finland
Tuberous sclerosis
100.3
9.4
10
*
H50.2
ICD-10 Finland
Vertical strabismus
4.3
9.4
33
77
T32.0
ICD-10 Finland
Corrosions involving less than 10% of body surface
+∞
9.4
9
*
R11
ICD-10 Finland
Nausea and vomiting
1.6
9.4
231
1468
SPAT1216
SPAT
Assessment of functional ability
1.4
9.3
480
3573
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.3
1253
10736
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
9.3
470
3490
A02BC03
ATC
lansoprazole; oral
1.3
9.2
913
7518
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
13.7
9.2
15
11
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
9.1
115
590
N88
ICPC
Epilepsy
4.9
9.1
28
57
AAF00
NOMESCO Finland
Ventriculostomy
4.6
9.1
30
66
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
8.3
9.1
19
23
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.4
9.0
72
300
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
7.0
9.0
21
30
G40
ICD-10 Finland
Epilepsy
3.8
9.0
36
95
N17
ICPC
Vertigo/dizziness
1.5
9.0
341
2393
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
18.6
8.9
13
7
AA1CF
NOMESCO Finland
Extensive MRI examination of brain with median intensity magnet
24.1
8.9
12
5
WX892
NOMESCO Finland
Monitored bed care
1.6
8.9
205
1280
SPAT1053
SPAT
Memory test
1.4
8.9
477
3575
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.3
8.8
980
8181
H54.4
ICD-10 Finland
Blindness, monocular
6.8
8.8
21
31
J01DB01
ATC
cefalexin; oral
1.3
8.8
2517
23489
N99
ICPC
Neurological disease other
3.2
8.8
43
134
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
8.7
293
2002
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
8.7
128
693
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
7.2
8.7
20
28
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
6.9
8.5
20
29
E23.2
ICD-10 Finland
Diabetes insipidus
9.0
8.5
17
19
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
8.5
118
629
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.4
1124
9585
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
8.4
202
1274
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
90.3
8.4
9
*
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
8.3
8
*
9537/0-C70.1
ICD-O-3
Transitional meningioma of spinal meninges
+∞
8.3
8
*
9531/0-C70.1
ICD-O-3
Meningothelial meningioma of spinal meninges
+∞
8.3
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
8.3
324
2287
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.6
8.3
27
59
R55
ICD-10 Finland
Syncope and collapse
1.5
8.2
301
2099
SPAT1043
SPAT
Audiometry
1.5
8.2
313
2202
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
8.1
287
1985
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
33.4
8.1
10
*
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
17.2
8.1
12
7
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
11.7
8.1
14
12
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.1
1024
8671
C08CA01
ATC
amlodipine; oral
1.3
8.0
1092
9323
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
8.0
1324
11552
N06AB04
ATC
citalopram; systemic
1.3
8.0
639
5096
ZZF00
NOMESCO Finland
Graft of adipose tissue
3.6
7.9
34
96
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
4.7
7.9
25
53
K90
ICPC
Stroke/cerebrovascular accident
2.1
7.8
83
398
G35
ICD-10 Finland
Multiple sclerosis
2.8
7.8
48
175
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
10.8
7.8
14
13
N03AX15
ATC
zonisamide; oral
10.8
7.8
14
13
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
9.4
7.8
15
16
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
7.8
151
900
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.1
7.8
82
392
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
7.7
127
716
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
7.7
596
4728
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
45.1
7.7
9
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
45.1
7.7
9
*
UDC00
NOMESCO Finland
Ear microscopy
1.6
7.7
199
1279
E22.1
ICD-10 Finland
Hyperprolactinaemia
4.2
7.7
27
64
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.7
1001
8495
N05BA04
ATC
oxazepam; oral
1.3
7.7
716
5829
G41.2
ICD-10 Finland
Complex partial status epilepticus
18.4
7.6
11
6
CE2W4
NOMESCO Finland
Eye movement mapping
6.7
7.6
18
27
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.5
7.5
56
227
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.4
768
6333
G93.0
ICD-10 Finland
Cerebral cysts
4.8
7.4
23
48
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
80.3
7.4
8
*
D42.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal meninges
80.3
7.4
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
7.4
386
2878
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
7.4
185
1183
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
7.6
7.4
16
21
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.4
75
355
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
7.3
993
8459
8000/0-C70.9
ICD-O-3
Neoplasm, benign of meninges, NOS
+∞
7.3
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.4
7.3
33
98
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
10.9
7.3
13
12
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
10.9
7.3
13
12
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.3
1113
9606
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.2
1761
15947
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.1
7.2
81
399
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
7.2
94
491
N07CA01
ATC
betahistine; oral
1.5
7.2
227
1531
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
7.2
476
3685
M54.5
ICD-10 Finland
Low back pain
1.3
7.2
921
7786
AA6AD
NOMESCO Finland
Cranial bones CT examination
30.1
7.1
9
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.5
7.1
54
222
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
6.0
7.1
18
30
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
3.6
7.1
30
85
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
8.8
7.0
14
16
R06AE07
ATC
cetirizine; oral
1.2
7.0
1248
10934
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
7.0
262
1832
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
7.0
505
3959
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.0
334
2450
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.8
7.0
115
651
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
3.1
7.0
35
113
SPAT1301
SPAT
No procedures
1.2
6.9
933
7930
N03AE01
ATC
clonazepam; systemic
1.6
6.8
163
1029
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
8.3
6.8
14
17
G04CA02
ATC
tamsulosin; oral
1.4
6.8
408
3113
H57.1
ICD-10 Finland
Ocular pain
2.0
6.8
86
445
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
6.8
164
1040
AAD00
NOMESCO Finland
Evacuation of epidural haematoma
40.1
6.8
8
*
H01AC01
ATC
somatropin; parenteral
16.7
6.7
10
6
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.7
593
4784
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.5
6.7
202
1350
R35
ICD-10 Finland
Polyuria
1.6
6.7
154
966
AAK99
NOMESCO Finland
Other operation on skull or dura
22.5
6.7
9
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
22.5
6.7
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.5
6.7
203
1361
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
6.7
847
7145
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
6.7
116
670
UJF32
NOMESCO Finland
Coloscopy
1.3
6.6
766
6391
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.6
609
4939
S09.9
ICD-10 Finland
Unspecified injury of head
2.9
6.6
38
132
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
12.3
6.6
11
9
L01
ICPC
Neck symptom/complaint
1.4
6.5
368
2780
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.5
361
2718
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.0
6.5
80
412
AAF15
NOMESCO Finland
Ventriculoatrial shunt
6.2
6.5
16
26
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
6.5
77
389
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
6.4
441
3431
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
70.0
6.4
7
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
70.0
6.4
7
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
70.0
6.4
7
*
B01AB05
ATC
enoxaparin; parenteral
1.2
6.4
910
7771
Z71.8
ICD-10 Finland
Other specified counselling
1.3
6.4
612
4988
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
14.3
6.4
10
7
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.4
763
6387
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
6.4
174
1137
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
6.4
281
2032
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
6.3
104
592
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
6.3
127
769
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
6.3
777
6528
22540
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
6.2
6
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
6.2
6
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
6.2
211
1447
D33.11
ICD-10 Finland
Brain stem
26.7
6.2
8
*
ZZR50
NOMESCO Finland
Mucoperiosteal flap
26.7
6.2
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.2
319
2373
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
6.2
163
1058
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.2
1306
11603
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
6.3
6.2
15
24
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.1
1406
12584
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
4.2
6.1
21
50
R50.9
ICD-10 Finland
Fever, unspecified
1.4
6.1
342
2578
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
6.1
192
1300
21899
ICD-8 Finland
Uterine fibroma
1.6
6.1
160
1036
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.9
6.1
35
123
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.1
6.0
63
304
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
10.0
6.0
11
11
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.0
287
2105

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
970
3773
3.10
182.39
5.6
7.0
1.0
1.2
mmol/l
0.91
702
2952
968
3793
3.08
179.36
5.7
7.0
5.0
5.1
kpa
5.88
935
3609
967
3791
3.07
178.98
5.7
7.0
16.3
12.2
kpa
55.63
933
3605
582
1675
3.92
175.72
5.1
8.7
24.1
24.4
mmol/l
1.78
567
1552
2684
19468
2.26
113.28
5.6
4.5
6.6
6.7
mmol/l
1.59
2580
18227
2482
17512
2.18
111.39
7.6
6.4
1.2
1.2
mmol/l
6.12
2161
14676
263
599
4.64
106.94
1.6
1.3
—
—
—
0
0
2297
15873
2.11
106.89
6.6
5.7
1.2
1.2
mmol/l
8.51
2115
14225
176
300
6.10
99.04
1.9
1.5
—
—
—
0
0
172
307
5.82
92.25
1.8
1.3
—
—
—
0
0
959
5015
2.22
89.80
2.1
2.0
28.9
29.8
s
3.72
926
4865
103
108
9.77
88.28
2.3
2.2
51.7
52.0
umol/l
0.02
85
81
1619
10414
1.96
85.41
2.3
2.1
157.5
187.8
u/l
1.44
1533
9704
251
655
4.03
85.17
1.6
1.3
69.6
24.7
e6/l
0.99
193
493
251
657
4.02
84.81
1.7
1.4
1545.8
1228.2
e6/l
0.22
197
527
1359
8388
1.96
79.58
3.8
3.7
93.6
90.7
%
4.18
1317
8156
1608
10669
1.87
74.21
2.4
2.4
—
—
—
0
0
253
747
3.56
71.63
1.4
1.3
706.4
537.9
mg/l
2.77
239
706
1924
13610
1.83
71.29
8.0
9.4
1.2
1.3
inr
2.35
496
3815
232
659
3.68
69.58
1.3
1.2
3.6
3.8
mmol/l
1.11
207
615
624
3017
2.28
68.91
2.8
2.1
368.9
374.1
nmol/l
0.23
579
2740
641
3154
2.24
67.76
1.4
1.4
—
—
—
0
0
624
3120
2.19
63.06
7.2
7.8
121.4
119.5
g/l
1.93
607
3000
654
3354
2.14
61.87
7.0
7.4
96.9
95.7
%
5.97
640
3229
2060
15393
1.73
58.66
4.0
4.0
—
—
—
0
0
455
2051
2.38
58.58
7.0
8.3
0.7
0.7
%
1.43
455
2038
1899
13892
1.73
58.25
2.4
2.1
—
—
—
0
0
1248
8140
1.79
57.18
2.3
2.3
—
—
—
0
0
454
2067
2.36
57.08
7.0
8.2
1.3
1.3
%
1.64
454
2054
134
293
4.70
57.03
1.9
1.4
—
—
—
0
0
452
2066
2.35
56.28
7.0
8.4
95.2
94.0
%
5.31
452
2056
203
657
3.21
49.47
2.7
1.6
408.2
304.3
mu/l
2.53
194
596
105
219
4.90
47.29
1.5
1.3
2.5
2.1
mmol/l
1.32
90
204
669
4099
1.77
35.52
6.3
6.4
104.8
104.3
mmol/l
2.08
657
4012
418
2205
2.01
35.44
5.8
5.1
—
—
—
0
0
58
92
6.39
35.02
2.6
2.2
0.7
1.3
ug/l
1.80
58
85
396
2108
1.98
32.61
8.8
7.2
24.9
24.7
mmol/l
0.59
381
1951
2604
22214
1.53
32.13
5.7
4.9
694.3
2042.2
e6/l
1.68
33
303
228
1014
2.33
29.78
5.1
4.1
3.8
3.8
mmol/l
1.68
222
955
58
115
5.11
27.76
3.1
2.8
28.9
29.2
umol/l
0.04
49
82
2118
17613
1.45
27.33
6.1
6.1
10.6
11.1
umol/l
1.08
1994
16645
2805
24640
1.51
27.31
4.6
4.3
12.9
13.4
mm/h
1.00
2608
22634
3466
32064
1.83
26.92
19.3
15.0
21.5
23.5
mg/l
3.51
3033
25542
2899
25691
1.52
26.62
4.9
4.3
14.9
14.9
pmol/l
0.11
2646
23176
2620
22746
1.48
26.61
5.4
4.7
—
—
—
0
0
462
2802
1.74
24.81
5.8
6.8
8.1
10.0
mmol/l
7.11
434
2667
242
1188
2.11
24.76
4.9
3.9
1.2
1.4
mmol/l
2.21
242
1167
3289
30130
1.64
24.70
5.9
5.2
3.0
2.1
mu/l
0.57
3021
27362
1942
16076
1.42
24.54
5.9
5.7
0.6
0.6
e9/l
0.28
1668
13730
1617
12961
1.43
24.46
4.1
3.8
39.4
85.7
ng/l
0.72
1171
9136
1948
16142
1.42
24.43
5.9
5.7
0.0
0.0
e9/l
0.17
1680
13806
1354
10519
1.44
24.25
4.5
3.9
7.4
7.4
ph
0.72
230
1953
116
413
2.87
23.97
3.7
5.2
348.9
361.9
umol/l
0.54
109
358
3566
33460
1.92
23.95
23.0
17.4
139.6
139.7
mmol/l
0.41
3519
32612
2894
25827
1.49
23.91
8.3
7.6
78.3
79.1
u/l
0.44
2730
24151
263
1351
2.02
23.80
5.3
4.5
—
—
—
0
0
1283
9902
1.44
23.66
3.5
3.2
47.9
74.5
e6/l
1.18
1007
7533
3571
33540
1.92
23.64
22.9
17.5
4.0
4.0
mmol/l
2.35
3519
32642
1450
11464
1.43
23.35
3.7
3.4
—
—
—
0
0
900
6506
1.50
23.12
3.1
2.7
524.6
526.6
mosm/kgh2o
0.11
785
5502
1973
16482
1.41
23.07
6.0
5.8
1.9
1.9
e9/l
0.16
1724
14363
780
5487
1.53
22.76
2.7
3.1
0.8
0.8
mmol/l
3.54
716
5071
1407
11106
1.42
22.68
5.9
5.8
—
—
—
0
0
1198
9185
1.44
22.68
3.4
3.1
0.4
0.5
e6/l
0.41
931
6913
905
6573
1.49
22.65
4.0
3.8
154.2
452.4
ng/l
1.29
690
5245
1993
16716
1.40
22.54
6.2
5.9
0.2
0.2
e9/l
2.48
1736
14524
1461
11646
1.41
22.12
4.0
3.7
70.3
118.4
e6/l
2.88
1075
8156
1810
14966
1.40
22.11
4.9
4.5
35.1
35.2
g/l
0.54
1673
13806
1779
14671
1.40
22.05
6.2
6.0
0.7
0.7
%
0.52
1650
13582
1829
15159
1.39
21.98
6.5
6.2
8.5
8.6
%
0.77
1703
14086
1175
9032
1.43
21.73
4.7
4.2
—
—
—
0
0
1818
15080
1.39
21.60
6.2
5.9
2.7
2.8
%
2.05
1685
13950
2211
18951
1.39
21.53
9.3
9.1
4.1
4.1
e9/l
0.51
1945
16496
1855
15506
1.38
20.68
6.4
6.1
27.5
27.7
%
0.34
1719
14317
912
6750
1.46
20.43
1.8
1.8
1103.5
1183.9
nmol/l
1.85
669
5030
123
496
2.53
19.97
1.6
1.3
11.8
14.6
u/l
1.13
98
393
1825
15281
1.37
19.80
6.1
5.8
57.8
57.4
%
0.77
1698
14172
625
4315
1.54
19.60
5.2
5.2
1.0
1.0
mmol/l
1.09
563
3961
423
2665
1.66
19.52
7.3
7.6
—
—
—
0
0
1146
8917
1.41
19.30
3.3
3.1
—
—
—
0
0
216
1121
1.98
18.98
2.0
2.2
478.8
669.1
ug/l
0.33
196
1051
1734
14499
1.36
18.52
2.1
2.0
97.4
96.4
pmol/l
0.32
850
7070
440
2855
1.61
17.99
6.3
6.3
1.4
1.3
mmol/l
1.07
427
2759
552
3776
1.54
17.94
1.8
1.8
—
—
—
0
0
297
1762
1.74
17.07
8.7
9.7
—
—
—
0
0
2290
20119
1.34
16.93
3.5
3.1
47.3
48.5
u/l
0.30
2114
18462
339
2110
1.67
16.32
3.0
3.2
4.3
4.4
pmol/l
2.12
304
1854
25
37
6.79
16.13
1.6
1.6
—
—
—
0
0
2578
23196
1.34
15.38
4.3
3.9
—
—
—
0
0
904
6983
1.39
15.26
2.8
2.6
6.2
6.3
e6/l
0.04
812
6084
3562
33956
1.67
15.22
22.2
17.7
74.7
75.3
umol/l
0.48
3562
33945
241
1403
1.77
14.79
6.1
5.5
1.5
1.6
%
1.45
224
1313
348
2235
1.61
14.76
2.3
2.4
17.5
24.9
au/ml
0.61
11
107
207
1166
1.82
14.19
1.6
1.3
31.8
35.1
iu/l
0.72
184
1013
318
2023
1.62
14.01
1.2
1.3
45.4
46.4
au/ml
—
9
94
59
196
3.04
13.92
1.2
1.1
9.5
13.0
nmol/l
0.14
14
41
1708
14648
1.30
13.74
2.4
2.3
78.0
79.9
nmol/l
2.00
1498
12966
696
5252
1.40
13.30
3.0
2.9
3.9
3.3
e6/l
0.62
388
2812
745
5703
1.38
13.03
2.8
2.7
1.1
1.3
e6/l
1.06
437
3245
59
207
2.88
12.68
1.2
1.1
55.0
38.5
mg/l
0.95
53
176
86
365
2.39
12.63
1.9
1.4
283.7
276.2
mosm/kgh2o
2.18
70
276
3468
33055
1.51
12.47
18.7
14.3
—
—
—
0
0
1444
12222
1.29
12.46
3.5
3.4
2.4
2.4
mmol/l
0.34
1227
10482
47
146
3.25
12.43
1.4
1.4
36.5
71.5
%
—
10
17
205
1205
1.74
12.19
2.6
2.2
10.6
12.1
nmol/l
1.72
172
1049
59
214
2.78
11.95
2.1
1.7
—
—
—
0
0
230
1405
1.68
11.89
6.3
5.5
1.0
0.9
%
1.54
214
1316
56
199
2.84
11.78
1.1
1.1
335.2
260.7
mg/l
0.94
50
174
608
4597
1.38
11.33
2.0
2.0
—
—
—
0
0
1263
10636
1.28
10.98
2.6
2.5
60.8
57.6
u/l
0.35
1143
9735
86
391
2.23
10.83
1.8
1.5
—
—
—
0
0
1226
10309
1.28
10.74
3.2
3.2
31.2
33.8
u/l
0.91
1144
9761
1203
10119
1.27
10.44
4.5
4.1
—
—
—
0
0
1574
13678
1.26
10.35
3.0
2.8
126.9
123.0
ug/l
0.23
1424
12519
92
441
2.11
10.17
1.7
1.4
48.0
37.1
mu/l
0.23
76
388
1815
16056
1.25
10.11
6.0
5.4
0.0
0.0
estimate
0.80
361
2937
137
759
1.83
10.00
8.2
7.8
10.7
11.1
mmol/l
0.81
121
680
137
759
1.83
10.00
8.2
7.8
107.3
105.0
mmol/l
6.26
121
680
1833
16251
1.24
9.94
4.5
4.1
0.0
0.0
estimate
1.32
351
2927
1806
15990
1.24
9.90
4.4
4.0
0.0
0.0
estimate
0.00
353
2928
3176
30041
1.33
9.89
6.4
6.0
39.7
40.0
mmol/mol
1.06
2919
27506
568
4343
1.36
9.78
1.4
1.3
542.6
561.0
titre
0.07
117
958
1015
8429
1.28
9.62
6.8
6.8
—
—
—
0
0
89
431
2.09
9.60
5.7
6.6
10.5
12.1
mg/l
2.44
84
400
20
41
4.90
9.30
1.4
1.2
49.0
51.3
%
0.07
13
19
172
1040
1.68
9.29
7.5
6.9
1.3
1.3
mmol/l
0.34
157
912
395
2884
1.41
8.97
3.9
3.4
89.1
87.1
ng/l
0.18
338
2422
331
2341
1.45
8.95
3.0
2.7
9.7
10.4
g/l
2.75
297
2126
425
3148
1.39
8.87
2.4
2.3
30.1
37.2
u/l
4.14
366
2679
1613
14219
1.23
8.86
10.6
9.7
0.0
0.0
e9/l
0.06
1311
11554
1196
10229
1.25
8.64
3.0
3.0
1491.6
1411.7
ng/l
0.25
1025
8778
495
3780
1.36
8.55
2.5
2.6
7.6
8.3
umol/l
0.23
412
3276
3305
31596
1.33
8.38
5.2
4.8
5.9
5.9
mmol/l
2.27
2992
28534
3523
34028
1.43
8.32
12.6
11.0
24.9
24.6
u/l
0.43
3415
32687
21
50
4.22
8.19
2.5
3.2
44.8
41.5
umol/l
0.24
21
39
42
159
2.66
7.95
1.2
1.2
—
—
—
0
0
560
4404
1.32
7.89
1.3
1.3
—
—
—
0
0
979
8260
1.25
7.86
1.6
1.5
20.3
21.2
nmol/l
1.07
832
6941
822
6802
1.27
7.80
3.2
3.0
2.5
2.5
mmol/l
0.57
698
5943
872
7274
1.26
7.71
1.9
1.7
1.5
1.2
mg/l
0.47
672
5576
141
854
1.68
7.63
1.5
1.4
17.3
19.3
iu/ml
—
5
21
118
681
1.76
7.60
1.2
1.4
74.3
61.3
mmol/l
2.26
99
551
1009
8593
1.24
7.36
2.4
2.2
3.0
3.1
mg/l
0.36
850
7301
79
412
1.94
7.05
1.6
1.3
250.2
278.1
pmol/l
0.37
65
311
175
1145
1.55
6.94
2.2
1.9
21.1
21.6
s
0.72
155
992
18
45
4.01
6.61
1.0
1.0
—
—
—
0
0
28
95
2.96
6.53
1.3
1.2
18.4
12.9
%
0.21
12
12
890
7564
1.23
6.51
1.7
1.7
10249746.2
27665173.7
pmol/l
0.84
722
6192
3604
35120
1.42
6.44
28.9
22.4
254.2
253.8
e9/l
0.14
3545
34146
3605
35140
1.42
6.34
29.1
22.5
132.0
132.7
g/l
2.97
3573
34574
3604
35129
1.42
6.34
28.8
22.3
90.9
91.3
fl
6.64
3570
34551
3604
35132
1.42
6.30
28.8
22.2
30.2
30.3
pg
4.59
3569
34554
3604
35134
1.42
6.28
28.9
22.3
4.4
4.4
e12/l
0.02
3539
34034
3604
35136
1.42
6.26
28.9
22.4
6.9
6.7
e9/l
4.77
3540
34033
463
3662
1.30
6.22
4.9
4.3
—
—
—
0
0
31
115
2.71
6.17
1.2
1.1
1875.0
368.5
ng/l
—
5
31
387
3000
1.32
6.01
3.9
3.5
1.7
2.1
mmol/l
1.22
325
2470
255
1853
1.40
5.99
1.9
1.8
1.5
1.4
g/l
0.17
225
1676
2969
28306
1.22
5.88
21.0
16.4
38.6
38.9
%
0.84
1997
19104
932
8030
1.21
5.87
1.3
1.3
—
—
—
0
0
382
2973
1.32
5.77
2.5
2.4
6.3
6.3
ug/l
0.00
316
2554
374
2906
1.32
5.72
2.3
2.7
65.4
66.2
g/l
1.68
332
2615
397
3117
1.31
5.63
3.8
3.4
—
7.4
—
0
17
272
2023
1.37
5.57
3.6
3.6
5.2
5.2
kpa
0.37
242
1873
3348
32376
1.27
5.53
5.4
5.2
2.8
2.8
mmol/l
0.12
3058
29466
11
21
5.25
5.52
1.4
1.3
22.0
45.9
%
0.99
11
14
103
630
1.65
5.48
2.2
2.9
29.0
33.5
umol/l
1.84
82
532
902
7798
1.20
5.43
4.1
4.0
—
—
—
0
0
268
2000
1.37
5.38
3.6
3.6
7.4
7.4
ph
2.68
34
254
3279
31652
1.25
5.38
4.9
4.6
4.7
4.7
mmol/l
0.48
3007
28958
384
3023
1.30
5.34
3.9
3.4
5.8
5.8
kpa
0.85
377
2940
684
5764
1.23
5.33
1.3
1.3
33.0
35.4
iu/ml
0.16
199
1831
579
4806
1.24
5.20
1.2
1.2
—
—
—
0
0
338
2628
1.31
5.16
4.5
4.1
0.2
0.2
%
0.08
115
707
3250
31384
1.23
5.05
4.8
4.6
1.5
1.5
mmol/l
3.10
2955
28521
2755
26205
1.18
5.04
24.9
19.8
331.1
331.0
g/l
0.37
2732
25992
34
147
2.32
5.00
2.2
2.8
827.0
1164.7
u/ml
0.60
34
147
152
1041
1.48
4.96
3.1
3.4
—
—
—
0
0
381
3038
1.28
4.81
2.5
3.0
170.7
194.7
ng/l
0.79
347
2770
350
2763
1.29
4.78
4.5
4.0
1.0
0.9
%
0.21
122
772
8
7
11.45
4.78
2.5
3.0
—
—
—
0
0
10
20
5.01
4.77
1.4
1.4
21.8
13.8
%
—
10
14
80
476
1.70
4.77
1.6
1.6
0.7
0.8
g/l
0.25
66
356
44
217
2.04
4.71
6.8
6.1
—
—
—
0
0
316
2470
1.30
4.66
4.5
4.1
0.0
0.6
%
1.49
98
606
2729
26017
1.17
4.54
23.5
18.4
13.8
13.8
%
0.32
2676
25427
27
110
2.46
4.54
1.2
1.2
—
—
—
0
0
78
468
1.68
4.53
1.5
1.3
—
—
—
0
0
60
334
1.81
4.52
1.4
1.4
0.3
0.3
nmol/l
0.05
43
240
310
2431
1.30
4.47
2.2
2.4
—
—
—
0
0
953
8406
1.18
4.47
2.8
2.6
3017.2
5718.2
umol/l
1.68
806
7167
180
1301
1.40
4.44
1.3
1.2
0.2
1.4
u/ml
2.47
15
123
1007
8927
1.17
4.43
1.6
1.6
1.4
1.3
mmol/l
1.03
867
7440
74
443
1.68
4.34
1.4
1.3
—
—
nmol/l
—
0
0
315
2491
1.29
4.27
3.8
2.8
4.7
4.5
kpa
0.74
305
2415
3135
30281
1.19
4.24
4.3
4.1
1.3
1.3
mmol/l
0.29
2824
27249
689
5948
1.19
4.12
1.5
1.4
2.3
2.4
g/l
1.72
401
3433
109
727
1.51
4.11
3.2
4.2
2.2
2.8
mmol/l
1.70
80
519
63
368
1.72
4.07
4.5
4.0
—
—
—
0
0
464
3861
1.23
4.06
1.5
1.4
—
—
—
0
0
969
8620
1.17
4.03
5.0
4.5
0.0
0.0
estimate
1.49
350
2883
134
936
1.45
4.02
1.7
1.6
0.2
0.2
g/l
0.94
122
890
55
310
1.79
4.01
5.8
4.7
9.9
48.2
u/ml
4.04
16
85
138
971
1.44
3.99
1.7
1.6
1.2
1.2
g/l
0.50
126
924
447
3713
1.23
3.98
1.7
1.6
—
—
—
0
0
103
685
1.52
3.95
2.6
2.9
8.5
8.0
kpa
0.56
95
632
102
688
1.50
3.68
2.5
2.5
15.4
16.0
%
0.78
50
346
9
16
5.64
3.65
1.2
1.2
2.7
0.9
%
—
9
10
20
79
2.54
3.62
1.1
1.1
0.7
0.7
umol/24h
0.02
11
41
287
2293
1.27
3.62
3.4
3.0
4.1
4.0
e9/l
0.18
204
1720
527
4496
1.20
3.59
2.8
2.5
21.3
22.1
%
0.56
461
3764
120
841
1.44
3.58
1.8
2.1
12.1
11.6
mg/l
0.11
108
775
123
867
1.43
3.56
3.2
4.0
7.4
7.4
ph
0.02
108
717
562
4829
1.19
3.53
2.7
2.4
2.3
2.3
g/l
0.49
513
4431
532
4554
1.20
3.49
25.1
25.9
1.4
1.4
inr
0.26
79
631
56
333
1.69
3.44
3.4
3.5
63.0
57.5
%
1.07
42
217
118
831
1.43
3.44
1.8
1.8
4.1
4.7
iu/l
0.25
40
287
34
173
1.97
3.43
4.1
3.5
—
—
—
0
0
114
799
1.44
3.41
2.6
3.1
25.1
25.1
mmol/l
0.02
99
697
174
1310
1.34
3.41
2.3
1.9
2.6
1.9
ug/l
0.33
137
1147
351
2892
1.24
3.40
1.6
1.5
—
—
—
0
0
86
572
1.52
3.35
2.3
2.8
—
—
—
0
0
355
2939
1.23
3.29
4.3
3.7
1.2
1.2
mmol/l
0.43
315
2536
42
233
1.81
3.29
1.2
1.2
—
—
—
0
0
46
263
1.76
3.26
1.1
1.1
—
—
—
0
0
309
2523
1.24
3.26
4.3
3.9
1.0
0.6
%
0.40
92
550
347
2870
1.23
3.25
3.7
3.7
—
—
—
0
0
189
1455
1.31
3.20
3.9
3.7
—
—
—
0
0
31
157
1.98
3.19
4.0
3.7
—
—
—
0
0
30
151
1.99
3.14
2.0
1.7
9.6
4.5
nmol/l
0.49
25
125
627
5496
1.17
3.11
1.3
1.3
6.6
13.0
u/ml
2.19
228
2059
43
245
1.76
3.10
2.4
2.4
—
—
—
0
0
149
1114
1.35
3.09
3.5
3.3
31.3
108.1
mg/l
0.91
123
932
37
202
1.84
3.07
4.1
3.0
—
—
—
0
0
41
233
1.77
2.99
1.2
1.1
110.0
177.3
titre
—
5
41
50
301
1.67
2.98
1.6
1.4
—
—
—
0
0
148
1113
1.34
2.97
3.6
3.3
28.2
55.1
mg/l
1.52
122
930
112
806
1.40
2.95
3.7
3.5
—
—
—
0
0
205
1615
1.28
2.94
3.9
3.1
25.2
25.5
mmol/l
0.68
200
1569
144
1081
1.35
2.92
3.6
3.3
1.2
1.5
ratio
—
8
91
191
1494
1.29
2.90
3.7
3.7
24.1
24.3
mmol/l
0.41
181
1344
33
177
1.87
2.90
3.1
2.3
858.4
671.5
e6/l
0.74
18
73
924
8368
1.14
2.89
4.4
3.7
—
—
—
0
0
598
5255
1.16
2.87
2.7
2.4
12.4
12.6
umol/l
0.25
553
4816
141
1063
1.34
2.80
1.1
1.1
—
—
—
0
0
99
708
1.41
2.72
2.8
3.6
—
—
—
0
0
104
751
1.40
2.71
2.0
2.2
124.8
127.1
g/l
0.46
70
530
11
37
2.98
2.69
1.1
1.1
49.0
89.6
ng/l
—
5
27
229
1852
1.25
2.68
1.4
1.3
—
—
—
0
0
245
2006
1.24
2.57
3.7
3.0
127.1
127.5
g/l
0.11
240
1956
19
87
2.19
2.57
1.2
1.1
189.5
322.1
pmol/l
1.48
11
64
48
300
1.61
2.53
1.6
1.4
0.3
0.4
g/l
1.02
38
210
48
300
1.61
2.53
1.6
1.4
2.6
2.8
g/l
0.36
38
213
48
300
1.61
2.53
1.6
1.4
5.9
7.1
g/l
1.90
38
211
79
552
1.44
2.50
4.3
3.5
1.8
1.4
%
0.28
63
426
384
3296
1.18
2.48
1.6
1.5
—
—
—
0
0
21
102
2.06
2.47
1.5
1.2
36.6
38.3
g/l
0.30
14
51
8
21
3.81
2.46
6.1
5.3
—
—
—
0
0
64
436
1.48
2.32
1.3
1.2
3.4
4.8
u/ml
0.69
25
173
435
3798
1.16
2.29
2.5
2.4
1.8
1.8
%
0.13
389
3350
772
7009
1.13
2.29
4.9
4.6
1.0
1.0
kg/l
0.00
140
1068
14
59
2.38
2.29
1.4
1.3
109.6
82.4
ng/l
0.59
14
59
11
41
2.69
2.27
1.1
1.1
1.5
1.7
umol/24h
0.38
11
41
289
2445
1.20
2.22
1.5
1.4
—
—
—
0
0
10
36
2.78
2.20
1.6
1.3
5.9
6.1
mmol/l
—
5
21
99
739
1.35
2.17
1.5
1.5
—
—
—
0
0
57
386
1.48
2.15
3.1
3.3
—
—
—
0
0
218
1801
1.22
2.15
4.5
3.7
—
—
—
0
0
61
419
1.46
2.15
2.7
2.4
—
—
—
0
0
44
282
1.57
2.13
2.5
1.8
—
1.1
—
0
12
117
898
1.31
2.13
5.3
4.7
—
—
—
0
0
163
1306
1.26
2.13
2.0
2.4
9.4
10.2
g/l
1.96
134
1084
270
2285
1.20
2.09
3.7
3.2
—
—
—
0
0
192
1571
1.23
2.08
2.0
2.0
—
—
—
0
0
158
1265
1.26
2.08
4.4
3.8
25.1
25.1
mmol/l
0.03
143
1153
758
6926
1.12
2.01
1.3
1.2
0.9
1.6
u/ml
3.46
179
1777
33
201
1.65
1.98
1.6
1.4
0.8
1.1
promille
0.42
23
156
742
6779
1.12
1.98
4.7
4.5
—
—
—
0
0
34
209
1.63
1.97
3.0
3.5
—
—
—
0
0
70
504
1.40
1.94
1.9
1.8
5526.6
2565.4
u/l
0.42
25
195
52
354
1.48
1.94
1.7
1.4
32.4
36.2
u/l
0.34
47
288
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
183
1504
1.23
1.93
3.1
2.5
0.6
0.7
%
0.20
176
1443
145
1166
1.25
1.87
2.9
3.0
0.3
0.3
g/l
0.41
63
417
42
277
1.52
1.84
1.4
1.3
—
—
—
0
0
368
3232
1.15
1.83
2.1
2.1
0.2
0.2
g/l
0.71
331
3015
42
280
1.51
1.76
1.3
1.1
—
—
—
0
0
118
934
1.27
1.76
1.1
1.1
—
—
—
0
0
36
232
1.56
1.75
2.1
2.3
—
—
—
0
0
146
1185
1.24
1.75
2.4
2.5
—
—
—
0
0
98
758
1.30
1.74
1.3
1.2
—
—
—
0
0
56
397
1.42
1.73
2.0
1.6
—
—
—
0
0
287
2489
1.17
1.71
1.2
1.2
—
—
—
0
0
137
1110
1.24
1.68
1.9
2.3
37.3
37.5
g/l
0.15
115
934
40
267
1.50
1.68
2.7
2.1
1.0
1.1
e9/l
0.24
18
173
16
83
1.93
1.64
1.1
1.1
—
—
—
0
0
28
173
1.62
1.63
11.3
11.4
—
—
—
0
0
959
10245
0.91
1.63
3.1
3.0
—
—
—
0
0
129
1045
1.24
1.60
1.5
1.4
297.0
280.2
ug/g
0.39
73
598
147
1213
1.22
1.55
1.7
1.6
—
—
—
0
0
19
107
1.78
1.54
1.1
1.1
1606.7
1701.7
miu/ml
0.11
19
107
650
5981
1.10
1.52
5.9
5.2
2.7
3.2
ug/l
0.92
577
5283
44
307
1.44
1.51
1.2
1.2
—
—
—
0
0
62
460
1.35
1.50
1.3
1.3
—
—
—
0
0
16
86
1.86
1.50
1.1
1.3
109.6
120.6
nmol/l
—
8
61
42
292
1.44
1.48
2.5
2.3
—
—
—
0
0
266
2323
1.16
1.48
1.2
1.2
—
—
—
0
0
54
394
1.38
1.46
1.8
1.7
—
—
—
0
0
88
691
1.28
1.45
1.2
1.2
—
—
—
0
0
11
52
2.12
1.44
1.2
1.6
81.0
113.0
ug/l
—
6
46
34
228
1.50
1.43
1.0
1.0
782.9
707.5
ng/l
0.31
20
143
63
474
1.33
1.41
1.2
1.2
300.8
292.0
u/ml
0.09
38
277
416
3755
1.12
1.41
1.3
1.3
—
—
—
0
0
62
467
1.33
1.38
1.8
1.8
—
—
—
0
0
321
2856
1.14
1.38
2.8
2.4
70.9
70.6
e9/l
0.07
254
2154
24
150
1.60
1.37
1.0
1.1
—
—
—
0
0
9
41
2.20
1.37
1.4
1.4
—
—
—
0
0
75
584
1.29
1.33
1.7
1.5
—
—
—
0
0
11
54
2.04
1.32
1.5
1.4
—
—
—
0
0
381
3440
1.12
1.30
3.4
3.2
0.9
0.8
ug/l
0.83
277
2384
42
301
1.40
1.29
1.1
1.1
—
—
—
0
0
205
1778
1.16
1.28
1.4
1.3
—
—
—
0
0
20
122
1.64
1.27
1.5
2.4
200.8
156.0
umol/l
—
9
68
15
84
1.79
1.27
1.2
1.3
107.5
64.6
mu/l
—
9
64
34
235
1.45
1.27
1.1
1.1
—
—
—
0
0
1081
10255
1.08
1.25
3.1
3.1
6.8
6.8
mmol/l
0.19
902
8508
73
573
1.28
1.24
1.7
2.0
0.8
0.8
nmol/l
0.06
66
473
57
433
1.32
1.23
1.2
1.2
—
—
—
0
0
27
179
1.51
1.23
1.1
1.1
1.0
1.0
ratio
—
8
60
61
469
1.31
1.21
1.4
1.3
103.8
120.1
u/ml
—
10
99
68
531
1.29
1.21
1.5
1.3
—
—
—
0
0
413
3765
1.11
1.19
2.0
2.1
111.7
133.3
ug/g
0.89
309
2907
17
101
1.69
1.19
1.9
1.8
—
—
—
0
0
13
71
1.83
1.19
1.1
1.1
—
—
—
0
0
38
272
1.40
1.19
1.2
1.2
—
—
—
0
0
65
506
1.29
1.19
1.8
1.7
—
—
—
0
0
105
865
1.22
1.19
1.3
1.3
14.3
7.7
u/ml
0.33
18
161
10
187
0.53
1.18
1.8
1.3
—
—
—
0
0
46
341
1.35
1.18
2.9
2.8
—
—
—
0
0
65
507
1.29
1.17
1.8
1.7
—
—
—
0
0
73
580
1.26
1.15
1.9
1.6
—
—
—
0
0
32
224
1.43
1.14
1.4
1.4
1883.4
1789.9
ml
—
8
50
1043
9915
1.07
1.13
3.1
3.2
544.1
361.7
mg/l
0.46
630
5945
65
510
1.28
1.13
1.8
1.7
—
—
—
0
0
1097
10449
1.07
1.12
3.8
3.9
8.1
8.1
mg/mmol
0.00
659
6270
176
1527
1.16
1.12
1.2
1.2
—
—
—
0
0
225
1987
1.14
1.12
2.6
2.5
—
—
—
0
0
94
771
1.22
1.12
2.7
3.0
1.6
1.6
mg/l
0.20
88
707
53
405
1.31
1.12
2.0
1.5
63.4
59.6
%
0.34
38
262
8
40
2.00
1.12
1.9
2.0
19.8
20.1
umol/l
—
8
40
103
854
1.21
1.11
1.3
1.3
2.1
6.4
u/ml
—
10
95
32
226
1.42
1.09
1.0
1.0
329.5
324.7
ng/l
0.03
22
143
10
52
1.93
1.06
1.0
1.0
—
—
—
0
0
63
498
1.27
1.05
1.6
1.7
—
—
—
0
0
39
288
1.36
1.04
1.9
2.2
1.4
2.0
u/field
0.60
15
111
173
1976
0.87
1.04
1.4
1.4
—
—
—
0
0
63
500
1.26
1.02
1.2
1.1
—
—
—
0
0
100
836
1.20
1.01
2.2
2.3
—
—
—
0
0
32
231
1.39
0.99
1.2
2.5
7.2
6.9
mmol/l
0.33
21
147
102
858
1.19
0.97
1.2
1.2
40.0
95.9
titre
—
6
63
118
1006
1.18
0.97
1.3
1.2
—
—
—
0
0
25
173
1.45
0.97
1.9
1.9
0.8
3.1
u/field
1.41
16
124
7
36
1.95
0.97
31.1
13.2
4.6
5.2
mmol/l
—
7
36
31
421
0.73
0.94
1.3
1.5
1650.4
2292.3
e6/l
0.52
24
311
32
235
1.36
0.91
2.3
2.5
—
—
—
0
0
418
3878
1.09
0.88
3.6
3.9
15.0
22.1
ug/l
0.34
333
3131
303
2770
1.10
0.88
5.2
4.3
—
—
—
0
0
15
228
0.66
0.85
1.4
1.5
—
—
—
0
0
14
88
1.59
0.84
1.4
1.9
—
—
—
0
0
38
293
1.30
0.81
3.2
2.8
21.8
28.2
mg/l
0.25
29
213
144
1271
1.14
0.79
3.0
3.2
2776.7
3475.2
u/ml
0.09
117
1069
0
24
0.00
0.79
0.0
1.1
—
0.1
—
0
12
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
48
384
1.25
0.78
1.4
1.3
—
—
—
0
0
30
225
1.34
0.78
1.9
2.0
41.8
43.9
%
—
6
23
30
395
0.76
0.78
1.1
1.1
1.6
1.5
g/l
0.57
24
352
18
123
1.47
0.77
1.2
1.4
—
—
—
0
0
53
430
1.24
0.77
2.0
2.5
—
—
—
0
0
17
115
1.48
0.76
1.0
1.0
0.2
0.9
u/ml
—
6
41
0
28
0.00
0.76
0.0
1.1
—
2.8
—
0
6
11
67
1.64
0.75
1.2
1.3
—
119.7
titre
—
0
13
22
158
1.39
0.74
1.2
1.3
133.6
134.3
nmol/l
0.04
22
158
15
218
0.69
0.71
1.3
1.4
—
—
—
0
0
78
664
1.18
0.71
1.3
1.3
187.8
215.4
miu/ml
0.26
33
297
62
517
1.20
0.71
1.8
1.4
—
—
—
0
0
31
238
1.30
0.70
1.9
2.2
639.6
626.4
ml
0.07
19
158
15
217
0.69
0.70
1.3
1.4
—
—
—
0
0
22
160
1.38
0.70
1.2
1.2
173.2
267.6
u/l
0.62
17
147
12
77
1.56
0.68
1.2
1.6
—
—
—
0
0
25
187
1.34
0.68
1.9
1.6
—
—
—
0
0
239
2195
1.09
0.68
2.9
3.9
43.0
65.8
u/ml
0.91
229
2111
76
650
1.17
0.67
2.7
2.7
—
—
—
0
0
49
402
1.22
0.66
2.7
2.0
4256.5
988.4
u/ml
0.36
49
393
18
128
1.41
0.65
2.4
2.6
—
—
—
0
0
206
1883
1.10
0.65
1.3
1.2
174.2
184.8
u/ml
0.08
187
1722
15
103
1.46
0.65
2.7
2.4
—
—
—
0
0
76
653
1.17
0.64
3.1
2.7
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
17.1
17.8
g/l
—
5
23
56
469
1.20
0.63
1.4
1.3
—
—
—
0
0
305
2846
1.08
0.61
1.5
1.5
—
—
—
0
0
14
96
1.46
0.61
2.3
1.5
—
—
—
0
0
92
806
1.14
0.61
3.5
3.2
0.8
0.8
nmol/l
0.50
66
624
46
380
1.21
0.60
1.1
1.2
—
—
—
0
0
26
334
0.78
0.60
1.4
1.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
0.1
—
0
10
39
318
1.23
0.58
1.1
1.1
1.0
1.6
u/ml
—
7
75
36
291
1.24
0.58
1.7
1.5
21.1
32.9
%
1.41
25
182
30
376
0.80
0.57
1.3
1.4
5947.5
74329.7
e6/l
2.33
19
218
49
410
1.20
0.57
1.1
1.3
40.9
48.0
u/ml
—
5
28
155
1410
1.10
0.56
1.4
1.5
—
—
—
0
0
114
1020
1.12
0.56
1.4
1.4
—
—
—
0
0
43
356
1.21
0.56
1.2
1.2
—
—
—
0
0
234
2172
1.08
0.55
1.2
1.2
164.7
148.1
iu/ml
0.25
78
815
9
60
1.50
0.54
2.6
1.7
—
—
—
0
0
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
22
169
1.30
0.53
1.1
1.3
—
1.6
—
0
13
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
15
108
1.39
0.53
1.1
1.1
—
—
—
0
0
36
295
1.22
0.52
1.1
1.2
338.9
368.7
nmol/l
0.39
28
247
43
359
1.20
0.52
2.0
2.1
—
—
—
0
0
24
187
1.29
0.52
1.1
1.2
—
—
—
0
0
20
260
0.77
0.52
1.4
1.7
—
—
—
0
0
6
40
1.50
0.51
2.7
2.5
—
—
—
0
0
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
118
1067
1.11
0.50
8.3
10.1
—
—
—
0
0
31
252
1.23
0.49
1.1
1.1
—
—
—
0
0
11
76
1.45
0.48
2.6
3.8
71.4
184.7
ng/l
—
5
32
130
1422
0.91
0.47
1.4
1.4
—
—
—
0
0
27
218
1.24
0.46
1.1
1.1
—
—
—
0
0
27
218
1.24
0.46
1.5
1.5
0.9
1.0
g/l
0.22
27
218
41
347
1.18
0.45
1.0
1.1
—
—
—
0
0
22
174
1.27
0.44
1.7
2.1
476.3
492.6
min
0.30
15
128
165
1530
1.08
0.43
1.7
1.7
1.6
1.6
g/l
0.03
143
1301
5
31
1.61
0.43
1.2
1.1
—
—
—
0
0
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
21
167
1.26
0.41
2.2
1.8
8.5
9.4
mmol/l
0.97
15
133
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
12
88
1.36
0.40
1.1
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.6
—
1.7
—
0
14
14
106
1.32
0.39
1.8
1.8
13.9
67.3
u/l
1.52
14
100
48
419
1.15
0.38
1.1
1.1
0.7
1.3
u/ml
0.51
15
163
12
89
1.35
0.37
1.2
1.1
—
—
—
0
0
97
886
1.10
0.37
1.1
1.1
—
—
—
0
0
10
72
1.39
0.36
1.6
1.8
—
—
—
0
0
40
347
1.15
0.35
1.0
1.1
—
—
—
0
0
9
126
0.71
0.35
8.7
12.8
1020.6
837.7
nmol/l
—
9
120
10
73
1.37
0.34
1.1
1.1
—
—
—
0
0
20
243
0.82
0.33
1.7
1.8
11.8
11.0
%
0.33
20
243
12
91
1.32
0.33
1.7
1.8
—
—
—
0
0
14
109
1.29
0.33
1.0
1.1
—
—
—
0
0
16
128
1.25
0.31
1.1
1.5
34.3
30.7
umol/l
0.91
16
122
41
361
1.14
0.31
1.0
1.1
1.8
3.4
u/ml
0.82
16
171
40
352
1.14
0.31
1.1
1.1
0.9
1.1
u/ml
0.12
13
143
7
53
1.32
0.30
2.7
2.8
—
—
—
0
0
7
55
1.27
0.30
1.1
1.7
—
—
—
0
0
21
176
1.19
0.28
1.8
1.5
—
—
—
0
0
16
130
1.23
0.28
1.2
1.1
—
—
—
0
0
48
431
1.12
0.28
1.4
1.3
—
—
—
0
0
42
374
1.12
0.28
1.3
1.2
—
—
—
0
0
15
122
1.23
0.27
1.7
1.9
—
—
—
0
0
5
74
0.68
0.26
4.0
3.0
3.3
7.7
mg/l
—
5
62
35
394
0.89
0.26
3.2
2.7
—
—
—
0
0
20
169
1.18
0.25
1.5
2.9
7.4
7.4
ph
—
8
58
45
406
1.11
0.25
1.2
1.2
—
—
—
0
0
29
256
1.13
0.23
1.1
1.1
6.6
3.1
u/ml
—
10
97
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
65
602
1.08
0.22
2.1
1.5
—
—
—
0
0
51
467
1.09
0.22
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
69
741
0.93
0.21
2.1
2.3
70.4
95.0
ug/min
0.31
30
433
52
478
1.09
0.21
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
8.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
0.1
—
0
5
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
8
105
0.76
0.21
2.1
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
5
39
355
1.10
0.20
3.0
1.9
—
—
—
0
0
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
19
165
1.15
0.19
1.6
1.5
—
—
—
0
0
19
165
1.15
0.19
1.0
1.0
—
—
—
0
0
24
213
1.13
0.18
2.0
2.0
17.0
14.2
%
—
9
84
20
175
1.14
0.18
1.0
1.0
—
—
—
0
0
32
352
0.91
0.18
1.7
1.6
—
—
—
0
0
38
413
0.92
0.17
1.3
1.7
—
—
—
0
0
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
8
72
1.11
0.16
1.0
1.0
—
—
—
0
0
49
458
1.07
0.15
2.2
2.9
—
—
—
0
0
69
727
0.95
0.14
3.1
3.8
30.1
25.9
mg/l
0.28
34
442
210
2044
1.03
0.14
1.3
1.3
—
—
—
0
0
10
84
1.19
0.14
1.0
1.1
—
—
—
0
0
8
99
0.81
0.13
1.0
1.4
—
—
—
0
0
31
335
0.92
0.13
1.7
1.3
20049.4
101096.4
e6/l
1.37
21
215
15
169
0.89
0.12
1.1
1.3
—
—
—
0
0
19
210
0.90
0.12
1.1
1.3
9.3
11.5
mmol/l
—
7
57
41
385
1.07
0.12
1.0
1.0
3.5
3.3
u/ml
0.05
18
152
42
444
0.95
0.10
1.2
1.1
13.9
1400.7
iu/ml
—
8
93
30
280
1.07
0.10
1.0
1.0
9.8
2.5
u/ml
—
8
102
5
44
1.14
0.10
2.6
1.7
1.7
3.1
mmol/l
—
5
35
25
233
1.07
0.09
1.2
1.1
—
—
—
0
0
12
107
1.12
0.08
2.0
1.3
—
—
—
0
0
6
58
1.03
0.08
2.3
2.7
—
—
—
0
0
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
32
338
0.95
0.08
1.6
1.5
—
—
—
0
0
7
66
1.06
0.08
1.3
1.3
—
—
—
0
0
6
70
0.86
0.07
1.7
1.3
—
—
—
0
0
8
74
1.08
0.07
2.6
1.5
—
—
—
0
0
7
85
0.82
0.07
2.3
1.8
-0.2
1.1
mmol/l
—
7
78
56
542
1.03
0.06
1.7
1.4
—
—
—
0
0
68
661
1.03
0.06
3.1
3.5
56.7
57.9
%
0.31
68
661
136
1383
0.98
0.05
2.1
1.8
—
—
—
0
0
24
252
0.95
0.05
1.5
1.3
—
—
—
0
0
18
170
1.06
0.04
1.4
2.1
—
—
—
0
0
35
362
0.97
0.04
1.0
1.1
—
—
—
0
0
327
3246
1.01
0.04
1.6
1.6
—
—
—
0
0
13
121
1.07
0.03
1.1
1.2
—
—
—
0
0
47
458
1.03
0.03
1.2
1.2
—
—
—
0
0
51
522
0.98
0.03
1.1
1.2
34.3
36.4
u/l
0.07
45
441
20
191
1.05
0.03
1.0
1.1
—
—
—
0
0
13
122
1.07
0.02
3.0
2.5
—
—
—
0
0
18
172
1.05
0.02
2.0
1.7
—
—
—
0
0
15
157
0.96
0.01
1.7
2.4
—
—
—
0
0
10
94
1.06
0.01
1.0
1.1
—
—
—
0
0
10
95
1.05
0.00
1.1
1.4
—
—
—
0
0
10
105
0.95
0.00
1.2
1.4
59.0
50.8
%
—
10
89
10
99
1.01
0.00
5.0
2.3
—
—
—
0
0
21
211
1.00
0.00
1.0
1.2
0.0
0.9
u/ml
—
5
102
83
829
1.00
0.00
2.1
1.6
8777.4
11504.9
e6/l
0.74
66
604
73
734
0.99
0.00
3.1
3.1
498.3
810.2
u/ml
0.22
62
669
10
96
1.04
0.00
1.4
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
8
81
0.99
0.00
2.8
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
6
67
0.90
0.00
5.2
6.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
4146.0
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
9
96
0.94
0.00
1.8
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
153.9
—
0
5
0
7
0.00
0.00
0.0
1.6
—
2.1
—
0
7
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
1.6
2.6
15.5
14.5
ml/dl
—
5
50
18
180
1.00
0.00
1.4
1.3
—
—
—
0
0
6
63
0.95
0.00
3.2
4.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
1205.0
—
0
6

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_MENINGES and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_MENINGES 1.507 [1.37, 1.65] < 0.001
Birth year 0.997 [0.99, 1.0] 0.453

During the follow-up period (1.1.1998 — 31.12.2019), 3477 out of 13400 females with CD2_BENIGN_MENINGES died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_MENINGES 1.823 [1.6, 2.08] < 0.001
Birth year 0.986 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1506 out of 4504 males with CD2_BENIGN_MENINGES died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MENINGES.

N-year risk Females Males
1 0.163% 0.304%
5 0.929% 2.125%
10 2.473% 4.988%
15 4.748% 9.416%
20 8.5% 15.69%

Relationships between endpoints

Index endpoint: CD2_BENIGN_MENINGES – Benign neoplasm of meninges

GWS hits: 8

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data